Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
4	4	Search

2025	Semi-mechanistic efficacy model for PARP + ATR inhibitors—application to rucaparib and talazoparib in combination with gartisertib in breast cancer PDXs British Journal of Cancer Claire C. Villette, Nathalie Dupuy, Frances A. Brightman, Astrid Zimmermann, Floriane Lignet, Frank T. Zenke, Nadia Terranova, Jayaprakasam Bolleddula, Samer El Bawab, Christophe Chassagnole
2024	Explaining in-vitro to in-vivo efficacy correlations in oncology pre-clinical development via a semi-mechanistic mathematical model Journal of Pharmacokinetics and Pharmacodynamics Heinrich J. Huber, Hitesh B. Mistry
2023	Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies Frontiers in Pharmacology Nicola Melillo, Jake Dickinson, Lu Tan, Hitesh B. Mistry, Heinrich J. Huber
2021	Exploring a model-based analysis of patient derived xenograft studies in oncology drug development PeerJ Jake Dickinson, Marcel de Matas, Paul A. Dickinson, Hitesh B. Mistry